noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Healthcare

Mitsui Global Investment

03/13/2026 | Press release | Archived content

Tacit Therapeutics Announces Series A Financing to Advance RNA Trans-Splicing Medicines for Inherited Diseases

Tacit Therapeutics, an RNA trans-splicing company developing programmable RNA repair medicines, today announced the closing of its Series A financing bringing the company's total capital raised to $19 million.

Mitsui Global Investment published this content on March 13, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 20, 2026 at 07:15 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format